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ORIGINAL ARTICLE
It is well known that liver tissue has the ability to
regenerate after injury. This characteristic of human
liver makes living related and small-for-size liver
transplantation successful.1–3 Among rat models
of liver regeneration, partial hepatectomy is a stan-
dard method for inducing or stimulating resid-
ual liver to regenerate.4 After partial hepatectomy,
approximately 95% of remaining hepatic cells,
rwhich are normally quiescent, rapidly re-ente
the cell cycle.5,6 Much is known about the molec-
ular mechanisms underlying liver regeneration
in the rat, but it is not really known whether the
same regenerative mechanisms are operative in
regenerating human liver. When we reviewed the
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literature on this topic, no human data were found.
This is important because the pattern and timing
of liver regeneration observed in nonhuman pri-
mate models are significantly different compared
with other nonprimate species.7 For example, the
peak expression of Ki-67, a marker of liver regener-
ation, occurs within hours in rat models, 72 hours
in dogs, and 2–3 weeks in Rhesus macaques.7
Species differences in liver regeneration, therefore,
exist.
Our study was aimed at determining changes
in mRNA expression profiles immediately after
hepatectomy in living donors who donated liver
tissue for liver transplantation. Changes in these
profiles were correlated with mechanisms for the
initial phase of liver regeneration reported in the
literature.
Materials and Methods
Patients
Our prospective study was conducted from March
2003 to August 2004 at National Taiwan University
Hospital’s transplant center. Consecutive living
donors willing to donate right hepatic lobes and
specimens were studied. Standard donor right lo-
bectomy was performed in each patient. Inflow
occlusion control was not performed during op-
eration. We sampled liver specimens from the
cutting edge of the remnant left lobe at the be-
ginning of liver resection and, about 5 hours later,
at the end of liver resection after the graft had been
removed. All tissue specimens were immediately
snap-frozen for subsequent molecular analysis.
All donors gave written informed consent. The
study was conducted according to the guidelines
of the Institutional Review Boards at National
Taiwan University Hospital.
RNA isolation and quality control
A small piece of liver tissue (< 1 cm3) was extracted
by Trizol® Reagent (Invitrogen Corp., Carlsbad,
CA, USA) followed by RNeasy Mini Kit (Qiagen
Inc., Valencia, CA, USA). Total RNA purified was
quantified by OD 260 nm using an ND-1000
spectrophotometer (NanoDrop Technologies Inc.,
Wilmington, DE, USA) and qualitatively by a Bio-
analyzer 2100 instrument (Agilent Technologies
Inc., Santa Clara, CA, USA).
Experimental design of oligo DNA microarray,
hybridization and scanning
ARNA (0.5 g of total) was amplified by a low RN
input fluor linear amp kit (Agilent Technologies
Inc.) and labeled with Cy3 or Cy5 (CyDye;
PerkinElmer Inc., Waltham, MA, USA) during the
in vitro transcription process. RNA from liver speci-
mens at the beginning was labeled by Cy5 and
t RNA from tissue samples obtained after graf
yremoval was labeled by Cy3. Correspondingl
fragmented labeled cRNA was then pooled and
hybridized to a Human 1A (version 2) oligo micro-
array (Agilent Technologies Inc.). gAfter washin
and drying by nitrogen gun blowing, microarrays
rwere scanned with an Agilent microarray scanne
(Agilent Technologies Inc.) at 535 nm for Cy3
and 625 nm for Cy5.
Data and statistical analysis
Signal intensities were quantified by feature extrac-
tion software (Agilent Technologies Inc.). Paired
signal intensity ratios (Cy3/Cy5) were normalized
with rank-invariant global Lowess regression analy-
sis by taking base two logarithms. Using trans-
formed data derived from each pair of competitive
hybridization images, we drew scatter diagrams
r to compare paired signal intensity ratios fo
different donors, and executed Pearson product-
moment correlation analysis. The given residuals
explained the logarithmic gene expression ratio.
We, therefore, selected genes whose average resid-
uals were more than 2.5-fold increased or less
than −2.5-fold decreased to get the most pro-
nounced expression changes during this period.
Results
Five of 34 donors were included with the samples
for qualitative analysis. The demographic data
rof the five donors are shown in Table 1. Simila
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gene expression patterns were found, as noted in
Figure 1. A total of 28 upregulated genes that
showed increases greater than the 2.5 mean log2
ratio expression and 14 downregulated genes that
showed decreases less than the −2.5 mean log2
ratio expression were collected. They are catego-
rized in Table 2 based on Gene Ontology Con-
sortium protocols. Gene names, systematic names
and description are listed in Table 3 in alphabet-
ical order. Acute-phase proteins such as serum
amyloid A1 (SAA1), A2 (SAA2), complement-
reactive protein (CRP), and heme oxygenase-1
were upregulated. Thyroid hormone responsive,
the adjuvant in the process of liver proliferation
(Figure 2), was downregulated. Genes related to
growth signal transduction such as G-protein
coupled receptor-30 were upregulated as was
suppressor of cytokine signaling 3.
Table 1. Demographic data of the five donors
Donor
Age Donated liver volume/whole
(yr)/sex original liver volume (mL)
1 24/M 1050/1851
2 24/M 800/1481
3 46/F 550/1156
4 35/M 790/1528
5 25/M 700/1518
STCH
CDC6
GPR30
BC031989,
THRSP
RASD1, NM_015714
CHI3L1
PHLDA2
ODC1,
S100A8
PBEF1
HMOX1, MT1K, CHST4, BACH2
ARMET, DNAJB9
SOD2, SAA2
CRP
AVPR1A
NNMT, A_23_P98042,
SOCS3, NM_022837,
RRS1, TNFRSF12A,
SAA1, BC018929
SERPINB10
CYP7A1
DGAT2
NM_017763
PALMD, NM_153345,
CLDN14
DGAT2L1
NEU4
VSNL1
NM_025176, TMBM7
iF gure 1. h d ff d ff d d l dT e i erent rows represent gene expression patterns in i erent onors. Re  represents upregu ate  genes
and green represents downregulated genes. Similar patterns of gene expression are noted in cluster analysis. Specific up-
and downregulated genes are labeled as shown.
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Discussion
Since the report of Higgins and Anderson,4 liver
regeneration has been studied mostly using rat
liver resection. In studies of liver regeneration using
animal models, sampling of liver tissues at serial
time points after partial hepatectomy is typically
collected. Although mechanisms can be inferred
from these animal studies, there have been no con-
firmational studies of regenerating human liver.
In fact, it is considered unethical to perform biop-
sies at several time points after partial hepatec-
tomy because patients would be under the risk of
the potential complications of those procedures
with no obvious benefits to the individual patients.
As one solution for resolving this dilemma, we
studied the initial response of remnant liver re-
generation immediately after partial hepatectomy.
In our previous unpublished study of regener-
ated liver volume after donor partial hepatectomy,
we found that smaller livers that remained after
operation had greater liver regenerated volumes.
We designed the current study, therefore, for live
donors after right hepatectomy. Our current re-
port is the first research study of human liver 
undergoing regeneration immediately after right
lobectomy for living-related liver transplantation.
These samples were taken from healthy volun-
teers with almost no confounding factors influ-
encing liver regeneration. This study, therefore, is
the first study of samples of human liver regener-
ation immediately after partial hepatectomy. All
donors were free from morbidity with additional
procedures of liver biopsy.
In this study, we found 28 upregulated and
r14 downregulated genes immediately after live
resection. After several hours, over 100 immediate-
early genes had been turned on and off, presum-
ably due to complex mechanisms that have been
seen in regeneration in rat liver.8 Many of these
genes account for acute phase responses. The
expression of these genes is definitely related to
liver resection and is seen as the initial response
of liver regeneration. Taub5 had reviewed the acute
phase response as the toxic damage or stimulus
to liver trigger the release of cytokines such as
interleukin-1 (IL-1), IL-6, and tumor necrosis
factor-α (TNF-α), which further cause the release
of acute-phase proteins such as SAA, CRP, and
fheme oxygenase-1. The genes for production o
acute-phase proteins SAA1, SAA2, CRP, and heme
oxygenase 1 were upregulated. Yang et al also
Table 2. Up- and downregulated genes category
Category
Upregulated gene names Downregulated gene names
(log2 ratio expression) (−log2 ratio expression)
Immune response SAA1 (3.42), SAA2 (3.40), CRP (3.42), –
CHST4 (2.84), S100A8 (2.62), SOD2 (2.57)
Cell growth and/or maintenance RASD1 (3.10), PBEF1 (2.98), NM_015714 –
(2.95), RRS1 (2.72), SOCS3 (2.54)
Cell death PHLDA2 (2.83) –
Signal transduction AVPR1A (2.94) GPR30 (2.80)
Biosynthesis ODC1 (3.20) DGAT2 (2.51)
Catabolism HMOX1 (2.98) –
Alcohol metabolism – CYP7A1 (2.61)
Macromolecule metabolism CDC6 (2.84), DNAJB9 (2.58) CLDN14 (3.54), NM_017763 (2.56)
Cell motility TNFRSF12A (2.92) –
Regulation of nucleometabolism BACH2 (2.79) BC031989 (2.88), THRSP (2.63)
Unclassified NNMT (2.99), ARMET (2.87), CHI3L1 (2.84), TMEM7 (3.03), NM_025176 (2.81),
BC018929 (2.72), MT1K (2.71), SERPINB1 VSNL1 (2.79), NEU4 (2.61),
(2.59), A_23_P98042, STCH (2.51), NM_153345 (2.58), DGAT2L1 (2.54),
NM_022837 (2.50) PALMD (2.54)
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Table 3. Gene names, systematic names, and description
Gene name Systematic name Description
Upregulated genes
A_23_P98042 A_23_P98042 Unknown
ARMET NM_006010 Arginine-rich, mutated in early stage tumors
AVPR1A NM_000706 Arginine vasopressin receptor 1A
BACH2 NM_021813 BTB and CNC homology 1, basic leucine zipper
transcription factor 2
BC018929 BC018929 Pleckstrin homology-like domain, family A, member 1
CDC6 NM_001254 CDC6 cell division cycle 6 homolog (S. cerevisiae)
CHI3L1 NM_001276 Chitinase 3-like 1 (cartilage glycoprotein-39)
CHST4 NM_005769 Carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 4
CRP NM_000567 Complement-reactive protein, pentraxin-related
DNAJB9 NM_012328 DnaJ (Hsp40) homolog, subfamily B, member 9
HMOX1 NM_002133 Heme oxygenase (decycling) 1
MT1K NM_005950 Metallothionein 1K
NM_015714 NM_015714 Putative lymphocyte G0/G1 switch gene
NM_022837 NM_022837 Hypothetical protein FLJ22833 
NNMT NM_006169 Nicotinamide N-methyltransferase
ODC1 NM_002539 Ornithine decarboxylase 1
PBEF1 NM_005746 Pre-B-cell colony enhancing factor 1, transcript variant 1
PHLDA2 NM_003311 Pleckstrin homology-like domain, family A, member 2
RASD1 NM_016084 RAS, dexamethasone-induced 1
RRS1 NM_015169 RRS1 ribosome biogenesis regulator homolog
(S. cerevisiae) 
S100A8 NM_002964 S100 calcium binding protein A8 (calgranulin A)
SAA1 NM_000331 Serum amyloid A1, transcript variant 1
SAA2 NM_030754 Serum amyloid A2
SERPINB1 NM_030666 Serine (or cysteine) proteinase inhibitor, clade B 
(ovalbumin), member 1
SOCS3 NM_003955 Suppressor of cytokine signaling 3
SOD2 NM_000636 Superoxide dismutase 2, mitochondrial
STCH NM_006948 Stress 70 protein chaperone, microsome-associated, 60 kDa
TNFRSF12A NM_016639 Tumor necrosis factor receptor superfamily, member 12A
Downregulated genes
BC031989 BC031989 Thyroid hormone responsive (SPOT14 homolog, rat)
CLDN14 NM_144492 Claudin 14 (CLDN14), transcript variant 1
CYP7A1 NM_000780 Cytochrome P450, family 7, subfamily A, polypeptide 1
DGAT2 NM_032564 Diacylglycerol O-acyltransferase homolog 2 (mouse)
DGAT2L1 NM_058165 Diacylglycerol O-acyltransferase 2 like 1
GPR30 NM_001505 G protein-coupled receptor 30
NEU4 NM_080741 Sialidase 4
NM_017763 NM_017763 Hypothetical protein FLJ20315
NM_025176 NM_025176 KIAA0980 protein
NM_153345 NM_153345 Hypothetical protein FLJ90586
PALMD NM_017734 Palmdelphin
THRSP NM_003251 Thyroid hormone responsive (SPOT14 homolog, rat)
TMEM7 NM_031440 Transmembrane protein 7
VSNL1 NM_003385 Visinin-like 1
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reported that overexpression of heme oxygenase-1
potentiates the survival of small-for-size liver
grafts in rats.9 These proteins help protect against
damage to the liver and are prerequisites for liver
regeneration. We can infer that rapid signal in-
formation flows from the insult to the expression
of responsive proteins during the resection period.
Interestingly, the genes related to signal trans-
duction, such as G protein-coupled receptor 30
(GPR30), were downregulated after liver resection.
The gene for suppressor of cytokine signaling 3
was upregulated. We know that liver regeneration
in rat models is composed of three sequential
phases: priming, proliferation, and growth inhi-
bition (Figure 2). The acute phase response is part
of the priming phase. The second phase of liver
regeneration, the proliferative phase, needs ad-
juvants such as norepinephrine, insulin, thyroid
hormone, and growth hormone for cell prolifer-
ation.10 In our study, the gene for thyroid hormone
responsive was downregulated. These findings
suggest that there might be a fast feedback in-
hibition response as the signal cascade of liver
regeneration is turned on and then passes by.
Liver regeneration is crucial for living-related
liver transplantation. Failed regeneration would
result in postoperative morbidity and mortality.
In the study by Cho et al, a remnant liver volume
of < 35% does not appear to be a contraindica-
tion for right liver procurement from living do-
nors.11 A second insult, however, in the setting of
relative hepatic insufficiency after liver donation
could initiate a potential fatal cycle of complica-
tions.11,12 rUnderstanding the genes involved in live
fregeneration should clarify the “physiology” o
liver regeneration and ultimately improve the re-
cgeneration process and further reverse pathologi
processes.
GPR30, a member of the G protein-coupled
receptor 1 family, encodes a multi-pass membrane
protein that localizes to the endoplasmic reticu-
lum. The protein binds estrogen, resulting in in-
ftracellular calcium mobilization and synthesis o
phosphatidylinositol 3,4,5-trisphosphate in the
nucleus.13 It was considered to be a potential sig-
naling pathway in breast carcinogenesis.14,15 The
significance of GPR30 in liver regeneration was
unknown. The stimulatory effects of estrogen on
cholangiocyte proliferation in bile duct ligated
rats involve the activation of the Src/Shc/ERK sig-
naling cascade.16 GPR30 may play a potential
significant role in cross-talk between estrogen and
the mitogen-activated protein kinase pathway in
bile duct regeneration after partial hepatectomy.
There are some limitations to our study. There
are changes that we may have missed in our study.
For example, IL-1 and IL-6 were upregulated.
However, they were not upregulated as much as
2.5 mean log2 rratio. Hepatocyte growth facto  
activator, which is necessary for efficient liver re-
generation,17 was downregulated in our study,
twhich further supported the hypothesis of fas
Growth
factors
(HGF,
TGF-α, etc.)
Acute phase
proteins
(SAA, CRP,
HO-1, etc.)
Priming
Proliferation
Growth
inhibition
Partial
hepatectomy
Cytokines
(TNF-α,
IL-1, IL-6,
SOCS3, etc.)
Adjuvants
(Insulin, GH,
TH, THRSP,
etc.)
Growth
factors or
receptors
(GPR30, etc.)
Growth
inhibitors
(TGF-β,
Activin, etc.)
Cell cycle
inhibitors
iF gure 2. l h d f l d lSequentia  p ases an  actors invo ve  in iver
regeneration. Acute-phase proteins and cytokines, mainly
serum amyloid A, complement-reactive protein, heme
oxygenase-1 (HO-1), tumor necrosis factor-α, interleukin-1 
(IL-1), IL-6, etc., act on hepatocytes after partial hepatectomy
in the initial priming phase. Growth factors, such as
hepatocyte growth factor and transforming growth factor-α, 
act on primed hepatocytes to make them through the
cell cycle and undergo DNA replication. Insulin, thyroid
hormone, and growth hormone act as adjuvants for liver 
regeneration. The factors that determine the termination 
of cell replication are not known but are likely to involve 
cell cycle inhibitors, turn-off of growth factor production,
and downregulated growth factor receptor. SOCS3 = suppressor
of cytokine signaling 3; THRSP = thyroid hormone responsive;
GPR30 = G protein-coupled receptor 30. [Modified from
Reference 10]
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feedback inhibition discussed previously. The
mean log2 ratio for this molecule, −1.17, also did
not meet our selection criteria. Moreover, we sam-
pled liver only at two time points due to ethical
difficulties of specimen sampling after the opera-
tion is complete. Serial gene expression profiles,
which can be shown well in animal studies,18–20
cannot be shown here, again because of ethical
issues. Animal models involve removal of two-
thirds of the liver for regeneration, while in our
study, a mean proportion of 49.8% of human
livers remained (for the safety of our donors).
Transplanted liver in the recipient regener-
ated faster than remnant liver in the donor with
regard to liver volume,2 but we have no data about
gene expression profiles in human grafts. Moreover,
many unknown and unclassified genes were ex-
cluded just because they were “unknown”, which
means there is still a long way to go before we
fully understand human mechanisms of liver 
regeneration.
Our report contains the first gene expression
profiles of human liver tissue after partial hepa-
tectomy. Acute-phase genes were upregulated,
while genes related to growth signaling were down-
regulated. Further study is needed to investigate
changes in other genes related to liver regenera-
tion in human.
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